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Abstract
We assessed infection prevention in Swiss hospitals via a national survey focusing on infection prevention practices prior to a large national
infection prevention initiative. Of the 59 hospitals that responded (77%), 98% had infection prevention teams and 40% very good or excellent
leadership support. However, a minority of hospitals used recommended infection prevention practices and surveillance systems regularly.
(Received 7 August 2019; accepted 22 November 2019; electronically published 13 April 2020)
Healthcare-associated infection (HAI) is a major concern worldwide.
In Europe an estimated 3.4 million patients are affected by HAI
annually.1 The Federal Offices of Public Health and the Swiss
Center for Infection Prevention Swissnoso are currently leading a
national program, “NOSO Strategy” (https://www.bag.admin.ch/
bag/en/home/strategie-und-politik/nationale-gesundheitsstrategien/
strategie-noso–spital–und-pflegeheiminfektionen/ueber-die-strategie.
html), to reduce infection risk in the Swiss healthcare system through
governance, monitoring, prevention, education, and research.
Catheter-associated urinary tract infection (CAUTI), ventilator-
associated pneumonia (VAP), central-line–associated bloodstream
infection (CLABSI), and surgical site infection (SSI) are prime
targets for most infection prevention programs because invasive
procedures represent modifiable risk factors. Additionally,
Clostridioides difficile infection (CDI) has caused repeated outbreaks
in hospitals globally, and organizational culture is an important
precondition for successful implementation of good infection pre-
vention practice.2 We investigated the status of structural,
procedural, and cultural aspects of infection prevention in Swiss
midsize-to-large acute-care hospitals prior to the rollout of the
NOSO Strategy.
Methods
Between October 2015 and March 2017, all Swiss acute-
care general and children’s hospitals with ≥3,000 annual
discharges (https://www.bfs.admin.ch/bfs/de/home/statistiken/
kataloge-datenbanken/publikationen.assetdetail.169879.html) were
invited to participate. Nonresponders received phone and e-mail
reminders.
Data were collected using a questionnaire developed by
Saint et al3 that covers general hospital characteristics, infection
prevention policies, infection prevention staffing, and use of spe-
cific practices related to surveillance and prevention of CAUTI,
CLABSI, VAP, and CDI. The survey was translated to German,
French, and Italian, and was pretested by infection prevention
specialists for the final online version (Survey Monkey, San
Mateo, CA).
Descriptive statistics, N (%) for categorical variables, and mean
(±SD) or median (range) for continuous variables were calculated
for hospital characteristics and specific infection prevention prac-
tices using SAS version 9.4 software (SAS Institute, Cary, NC) and
Stata/SE version 14.2 software for Mac (StataCorp, College Station,
TX). The 2 affirmative values of incremental rating scales were
expressed as proportions of positive answers. “Don’t know” was
recoded as negative. Missing answers were excluded.
According to the Swiss law on research on humans, ethics
approval was waived. Responses remained confidential.
Results
Overall, 77 hospitals met the inclusion criteria and were invited; 59
hospitals (77%) responded, mainly through infection prevention
nurse practitioners (93%). Of these hospitals, 3 were university
hospitals (return rate, 60%), 3 were children’s hospitals (100%),
26 (77%) were secondary care centers, and 27 (71%) were primary
care centers; 10 (return rate, 77%) were French-speaking hospitals,
47 (77%) were German-speaking hospitals, and 2 (67%) were
Italian-speaking hospitals.
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Infrastructure
Select hospital and infection prevention infrastructure character-
istics are displayed in Supplementary Table 1 (online). All hospitals
reported having infection prevention policies. All but 1 hospital
had infection prevention professional(s). Infection prevention
staffing varied markedly; only 16 (27%) hospitals met the require-
ment for 1 infection prevention nurse per 100 acute-care beds.2
Culture
Although most respondents (48 of 58, 83%) felt that hospital lead-
ership encouraged putting patient safety at the center of efforts,
only 23 of 58 (40%) reported having very good or excellent support
from hospital leadership for infection prevention (Supplementary
Fig. 1 online).
Practices
Median use of recommended infection prevention practices was
18% (range, 10%–86%) for CAUTI, 48.5% (range, 0%–89%) for
CLABSI, 44% (range, 2%–63%) for VAP, and 64% (range, 40%–
86%) for CDI (Fig. 1). In general, perceived evidence matched
practice use with the exception of CAUTI, for which perceived
evidence strength mismatched published evidence strength.
Indications for urinary catheters included prolonged surgery in
46 of 51 hospitals (90%), urinary output monitoring in 41 of 52
hospitals (79%), urinary obstruction in 33 of 52 hospitals (63%),
skin ulceration in 8 of 52 hospitals (15%), incontinence in 7 of
51 hospitals (14%), nursing workload in 1 of 52 hospitals (2%),
and patient or family wish in 0 of 50 hospitals (0%). Use of a
central-line insertion checklist was reported by 37 of 54 hospitals
(69%), an insertion kit was used in 46 of 55 hospitals (84%), and
reassessment of central-line indication during clinical rounds
occurred in 44 of 52 hospitals (85%). Early mobilization for
VAP prevention was applied by 43 of 49 hospitals (88%).
Surveillance
Surveillance varied considerably by HAI type and hospital (Fig. 2).
Local surveillance schemes for at least 1 HAI were reported by 34 of
59 hospitals (58%). Repeated HAI prevalence surveys were per-
formed in 16 of 59 hospitals (27%). SSI surveillance was almost
universal through the national surveillance scheme 57 of 59
hospitals (97%). Hospital-acquired pneumonia was surveilled in
7 of 59 hospitals (12%).
Applying multivariable models, we found no relevant correla-
tions between staffing levels, leadership support, and perceived
importance of HAI prevention with various infection prevention
practices and monitoring activities (data not shown).
Fig. 1. Use of prevention practices and perception of the strength of supporting evidence. The line graphs represent the use of preventive practices. Lines represent the level of
practice; dots represent the perception of the supporting evidence; diamonds represent the evidence form authoritative infection prevention guidelines. A high level of evidence
appears at 100%, moderate level at 75%, and a low level at 50% (for references, see the text). For prevention practices, 5-point scales from “never” to “always” were transformed
into a dichotomous variable recoding “almost always” and “always” as 1 (“yes”) and the remainder as 0 (“no”). Missing answers and “don’t know” were excluded from the
calculation of proportions. Note. C. difficile, Clostridioides difficile. *Not recommended practice. **No evidence level reported in guidelines.
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Discussion
We conducted a comprehensive, national survey of Swiss acute-
care hospitals to ascertain the state of infection prevention struc-
ture, practices, and organizational culture to prevent the most
common HAIs prior to the rollout of a national infection preven-
tion program.
Our study has several main findings. First, almost all Swiss gen-
eral acute care hospitals had an infection prevention practitioner or
team and infection prevention policies. However, the staffing of
infection prevention teams inmost hospitals did notmeet the latest
international recommendations.4–7 Second, perceived hospital
leadership support for infection prevention was modest in most
hospitals. Third, only aminority of hospitals sustained surveillance
systems for HAI. Finally, specific prevention practices were imple-
mented to varying degrees, being low for CAUTI and higher for
CDI prevention.
Similar versions of the questionnaire3 distributed in the present
survey have been distributed in other countries. A random sample of
900 US acute-care hospitals reported higher use of most prevention
practices than Switzerland. In contrast to this study, the perceived
importance of preventing specific HAIs and the certification status
of the infection prevention leader were significantly associated with
the use of prevention practices in US hospitals.3 Findings among
Thai and Japanese hospitals suggested that increased organizational
commitment toward safety culture and participating in infection
prevention collaborative networks contribute to improvements in
HAI prevention.8,9 In line with our findings, a European survey
among 309 hospitals found that most hospitals featured CLABSI
surveillance.10
Importantly, we identified a gap between perceived solid evi-
dence to support many CAUTI prevention practices, especially
system-level elements (eg, catheters reminders and nurse-initiated
stop orders and use of alternative catheterization), consistent with
low perceived awareness of CAUTI by hospital leadership.
However, perceived strength of evidence for many practices mis-
matched the guideline-reported strength of evidence but matched
actual use, a correlation found by others.11 This finding might just
reflect the lacunar nature of research against common sense,
demonstrated by aseptic technique during urinary and central-line
insertion, for which the actual evidence is low6 to moderate4
although it was perceived as being high and was followed by a high
level of use.
Whereas respondents perceived high levels of encouragement
for patient safety, they felt less confident that their colleagues
would be open to changes or that it would be easy to implement
evidence-based guidelines. Perhaps most notably, only a minority
felt that leadership support for infection prevention was very good
to excellent. We also found that the level of perceived leadership
interest did not always match the application of practices.
Our study has limitations. First, survey findings depend on the
person responding. We sought to mitigate this by asking the
respondent to crosscheck their opinions with knowledgeable col-
leagues. Second, surgical site infections and other infection preven-
tion topics were not covered in this survey, as we kept the number
of survey questions manageable in favor of a high return rate.
In conclusion, this comprehensive survey of infection preven-
tion structure, practices, and organizational culture revealed a need
for better infection prevention staffing in most Swiss acute-care
hospitals and increased application of evidenced-based infection
prevention practices and surveillance; this was especially so for
CAUTI prevention. Although the presence of infection prevention
teams and patient safety culture were rated relatively high, support
for infection prevention by hospital leadership can likely be
improved. The Swiss national infection prevention program will
ideally address the specific hospital-level deficiencies noted in this
national survey.
Supplementary material. To view supplementary material for this article,
please visit https://doi.org/10.1017/ice.2019.351.
Fig. 2. Healthcare-associated infection surveil-
lance activities. Feedback of infection rates to
healthcare providers was coded as present when
it was indicated as at least given to some units of
the hospital. Missing answers were excluded
from the calculation of proportions.
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